Overview

A Combination Therapy In Patients With Social Anxiety Disorder

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of a combination of Vestipitant and Paroxetine in patients with Social Anxiety Disorder (SAD)
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Paroxetine
Vestipitant